Results demonstrated significantly reduced primary tumour growth and metastatic progression rates in animals with CAIX‐deficient tumours, while the CAIX‐expressing tumours had vascularised phenotypes with prominent central areas of coagulative necrosis. The gene discussed is CA9; the disease is neoplasm.